Search - tctmd.com

Displaying 521 - 540 of 636

Sort: Relevancy | Date

Presentation TCT 2013

Early Safety of the Amplatzer Cardiac Plug™ for Left Atrial Appendage Occlusion

Presenter: David Meerkin, Adi Butnaru, Dmitry Dratva, Olivier Bertrand, Dan Tzivoni

January 31, 2013

Presentation TCT 2013

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Presenter: Bryan Yan, Chow Innes, Yat Yin Lam, Vivian Lee, Cheuk Man Yu

January 31, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

Presentation

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Presenter: Vivek Y. Reddy

January 29, 2013

News Industry News

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

January 17, 2013

News Daily News

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

L.A. McKeown

January 16, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

Presentation

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Presenter: A. Massumi

January 14, 2013

News Conference News TCT 2012

Watchman LAA Effective in Patients Contraindicated for Warfarin

October 26, 2012

Presentation TCT 2012

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Presenter: Vivek Reddy

October 25, 2012

Presentation TCT 2012

Promising LAA Closure Devices and the Structural Heart Team Approach

Presenter: Carlos Pedra

October 25, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

Presentation TCT 2012

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Presenter: David Muller

October 24, 2012

Presentation TCT 2012

Tough Call During an LAA Occlusion

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

The SentreHeart Transpericardial Approach to LAA Occlusion

Presenter: Steven Yakubov

October 24, 2012

Presentation TCT 2012

Surgical LAA Exclusion: Is It Effective?

Presenter: A. Marc Gillinov

October 24, 2012

Presentation TCT 2012

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Closure of the Left Atrial Appendage: Transcatheter Approaches and Results

Presenter: Randall Lee

October 24, 2012

Presentation TCT 2012

Closure of the Left Atrial Appendage: Surgical Approaches and Results

Presenter: A. Marc Gillinov

October 24, 2012

Advertisement

Early Safety of the Amplatzer Cardiac Plug™ for Left Atrial Appendage Occlusion

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Watchman LAA Effective in Patients Contraindicated for Warfarin

Will Transcatheter Left Atrial Appendage Closure Transform Management of Atrial Fibrillation?

Promising LAA Closure Devices and the Structural Heart Team Approach

Novel Devices Provide Options for LAA Therapy

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Tough Call During an LAA Occlusion

The SentreHeart Transpericardial Approach to LAA Occlusion

Surgical LAA Exclusion: Is It Effective?

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Closure of the Left Atrial Appendage: Transcatheter Approaches and Results

Closure of the Left Atrial Appendage: Surgical Approaches and Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content